Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2015 Jan;261(1):97-103.
doi: 10.1097/SLA.0000000000000688.

Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes

Affiliations
Observational Study

Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes

Meera Kotagal et al. Ann Surg. 2015 Jan.

Abstract

Objective: To study the association between diabetes status, perioperative hyperglycemia, and adverse events in a statewide surgical cohort.

Background: Perioperative hyperglycemia may increase the risk of adverse events more significantly in patients without diabetes (NDM) than in those with diabetes (DM).

Methods: Using data from the Surgical Care and Outcomes Assessment Program, a cohort study (2010-2012) evaluated diabetes status, perioperative hyperglycemia, and composite adverse events in abdominal, vascular, and spine surgery at 53 hospitals in Washington State.

Results: Among 40,836 patients (mean age, 54 years; 53.6% women), 19% had diabetes; 47% underwent a perioperative blood glucose (BG) test, and of those, 18% had BG ≥180 mg/dL. DM patients had a higher rate of adverse events (12% vs 9%, P < 0.001) than NDM patients. After adjustment, among NDM patients, those with hyperglycemia had an increased risk of adverse events compared with those with normal BG. Among NDM patients, there was a dose-response relationship between the level of BG and composite adverse events [odds ratio (OR), 1.3 for BG 125-180 (95% confidence interval (CI), 1.1-1.5); OR, 1.6 for BG ≥180 (95% CI, 1.3-2.1)]. Conversely, hyperglycemic DM patients did not have an increased risk of adverse events, including those with a BG 180 or more (OR, 0.8; 95% CI, 0.6-1.0). NDM patients were less likely to receive insulin at each BG level.

Conclusions: For NDM patients, but not DM patients, the risk of adverse events was linked to hyperglycemia. Underlying this paradoxical effect may be the underuse of insulin, but also that hyperglycemia indicates higher levels of stress in NDM patients than in DM patients.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flow diagram (ovals indicate patients who comprise the study cohort).
FIGURE 2
FIGURE 2
Receipt of insulin, by glucose level. Differences were statistically significant between patients at different levels of hyperglycemia for both patients with and without diabetes.
FIGURE 3
FIGURE 3
Adverse events, by diabetes status and postoperative glucose level.

References

    1. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infections in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356–361. - PubMed
    1. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607–612. - PubMed
    1. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications: deep vs superficial infection. Chest. 1996;110:1173–1178. - PubMed
    1. Vuorisalo S, Haukipuro K, Pokela R, et al. Risk features for surgical-site infections in coronary artery bypass surgery. Infect Control Hosp Epidemiol. 1998;19:240–247. - PubMed
    1. Slaughter MS, Olson MM, Lee JT, Jr, et al. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg. 1993;56:1063–1068. - PubMed

Publication types